Metagenomi, Inc. Common Stock
MGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.7% | 106.3% | -57.1% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 84.7% | -164.4% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -222.9% | -230.8% | -641.2% | -199.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -235.5% | -233.9% | -606.7% | -243.4% |
| EPS Diluted | -0.55 | -0.54 | -0.68 | -0.63 |
| % Growth | -1.9% | 20.6% | -7.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |